impurities – Pharma GMP

Impurity Profiling in QC: From Method Development to Routine Release

digi — Tue, 25 Nov 2025 10:42:04 +0000

Impurity Profiling in QC: From Method Development to Routine Release Step-by-Step Tutorial Guide to Impurity Profiling in QC Laboratories Impurity profiling in QC laboratories is a critical component of pharmaceutical quality control designed to detect, quantify, and monitor impurities such as related substances and degradation products throughout the drug product’s lifecycle. The process begins in...

How to Set and Justify Impurity Limits in Specifications

digi — Tue, 25 Nov 2025 10:39:04 +0000

How to Set and Justify Impurity Limits in Specifications Step-by-Step Guide to Setting and Justifying Impurity Limits in Specifications Impurity profiling in QC is a fundamental aspect of pharmaceutical quality control, ensuring the safety, efficacy, and regulatory compliance of drug substances and products. Setting and justifying impurity limits in product specifications demands a systematic and...

Method Development Strategies for Sensitive Impurity Profiling

digi — Tue, 25 Nov 2025 10:36:04 +0000

Method Development Strategies for Sensitive Impurity Profiling Comprehensive Guide to Method Development Strategies for Sensitive Impurity Profiling in QC Impurity profiling in QC laboratories is a critical aspect of pharmaceutical quality control, ensuring that drug substances and drug products meet stringent regulatory requirements for purity and safety. Sensitive impurity profiling demands the development of analytical...

Case Studies: Unexpected Impurities and How QC Labs Responded

digi — Tue, 25 Nov 2025 10:33:04 +0000

Case Studies: Unexpected Impurities and How QC Labs Responded Case Studies Detailing Unexpected Impurities and QC Laboratory Responses In pharmaceutical manufacturing, impurity profiling in QC laboratories is an indispensable activity ensuring drug substance and drug product safety, efficacy, and compliance with regulatory requirements. Although routine impurity screening is well-established, the emergence of unexpected impurities presents...

Good Manufacturing Practice for Active Pharmaceutical Ingredients: Impurity Control and Specifications

digi — Fri, 14 Nov 2025 22:41:47 +0000

Good Manufacturing Practice for Active Pharmaceutical Ingredients: Impurity Control and Specifications Comprehensive Guide to Good Manufacturing Practice for Active Pharmaceutical Ingredients: Managing Impurity Control and Specifications In pharmaceutical manufacturing, adherence to good manufacturing practice for active pharmaceutical ingredients (API GMP) is imperative to ensure product safety, quality, and compliance with global regulatory expectations. One of...